VF
MRTX

Virtu Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Virtu Financial’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,350
Closed -$229K – 2122
2023
Q2 		$229K Sell
6,350
-4,273
-40% -$176K 0.02% 742
2023
Q1 		$395K Buy
+10,623
New +$478K 0.04% 433
2022
Q4 		– Sell
-9,423
Closed -$658K – 2333
2022
Q3 		$658K Sell
9,423
-647
-6% -$47.9K 0.06% 295
2022
Q2 		$676K Buy
+10,070
New +$640K 0.06% 294
2021
Q3 		– Sell
-7,607
Closed -$1.23M – 2118
2021
Q2 		$1.23M Buy
+7,607
New +$1.22M 0.12% 149
2021
Q1 		– Sell
-1,886
Closed -$414K – 2170
2020
Q4 		$414K Sell
1,886
-2,741
-59% -$593K 0.04% 501
2020
Q3 		$768K Buy
+4,627
New +$633K 0.13% 177
2019
Q4 		– Sell
-3,776
Closed -$294K – 1952
2019
Q3 		$294K Buy
+3,776
New +$354K 0.02% 773
2019
Q2 		– Sell
-3,558
Closed -$261K – 1967
2019
Q1 		$261K Buy
+3,558
New +$242K 0.01% 856

Other funds holding MRTX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's MRTX Position: Q3 2023 in Review

Virtu Financial sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2023, closing a stake of 6,350 shares — an estimated $229K sold.

Virtu Financial first reported a position in MRTX in Q1 2019 and held it in 9 quarters. The position peaked at $1.23M in Q2 2021. 213 funds tracked by Wall St. Rank hold MRTX as of Q3 2023.

  • Virtu Financial reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 6,350 Mirati Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $229K.
  • Virtu Financial first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • Virtu Financial's Mirati Therapeutics, Inc. Common Stock position peaked at $1.23M in Q2 2021.
  • 213 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.